ADVFN Logo

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

ASND Ascendis Pharma AS

151,17
2,73 (1,84%)
29 Mar 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 295 063
Prix Achat 145,48
Prix Vente 156,31
Actualités -
Nom Action Symbole Action Marché Type
Ascendis Pharma AS ASND NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
2,73 1,84% 151,17 01:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
149,15 144,66 151,59 151,17 148,44
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne
5 865 295 063  148,40  43 788 680 -
Dernière Transaction Type Quantités échangées Prix transaction Devise
21:55:56 14  151,50 USD

Flux d'options Ascendis Pharma AS (ASND)

Flux global

Haussier

Prime nette

41k

Calls / Puts

200,00%

Ach. / Vent.

0,00%

OTM / ITM

200,00%

Sweeps Ratio

0,00%

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
0 0,00 - 200,64M -481,45M - -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Ascendis Pharma AS

Date Heure Source Titre
07/3/202417:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
06/3/202403:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202414:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202414:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202413:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
04/3/202421:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
04/3/202421:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
04/3/202420:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
04/3/202420:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
04/3/202414:30GlobeNewswire Inc.Ascendis Pharma to Participate in the Leerink Partners..
01/3/202417:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
29/2/202423:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securities

Forum Ascendis Pharma AS

Aucune Discussion TrouvéeAjouter une Discussion

Historiques

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine0,000,000,000,0000,000,00%
1 mois0,000,000,000,0000,000,00%
3 mois0,000,000,000,0000,000,00%
6 mois0,000,000,000,0000,000,00%
1 an0,000,000,000,0000,000,00%
3 ans0,000,000,000,0000,000,00%
5 ans0,000,000,000,0000,000,00%

Dernières Valeurs Consultées

Delayed Upgrade Clock